4
Changes in Ownership
PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-020823
President and CEO sold 9,712 shares at $11.36 ($110,328)
- President and CEO acquired 21,514 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KANE MATTHEW R. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 1 in the form | +21,514 | $0.04 | $861 | 1,939,180 | D |
| 2021-03-12 | Sale : show line 2 in the form | −9,712 | $11.36 | $110,328 | 1,929,468 | D |
| Open-market sales · 9,712 sh · avg $11.36 · $110,328 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-12 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −21,514 | 129,084 | D |
Loading xslF345X03/doc4.xml…